Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: 2-Methoxystypandrone (2-MS), isolated from the roots of Polygonum cuspidatum, is a potent dual inhibitor of the STAT3 and NF-κB pathways.

Objective: To investigate the molecular targets and mechanisms of 2-MS.

Method: A biotin-conjugated 2-MS analog, named 2-MS-Biotin, was designed and synthesized. The effects of 2-MS-Biotin on the STAT3 and NF-κB pathways were examined by Western blotting. The cytotoxicity of 2- MS-Biotin was evaluated using real-time cell analysis system. Proteins directly bound to 2-MS-Biotin were pulled down through streptavidin agarose beads and were detected using Western blotting.

Results: 2-MS-Biotin retained the inhibition activities of the parent compound 2-MS on the STAT3 and NF-κB pathways as well as on cancer cell growth. Also, JAK2 and IKK proteins can be effectively pulled down by 2- MS-Biotin.

Conclusion: Using 2-MS-Biotin as a tool, both JAK2 and IKK were identified as the targets of 2-MS.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1871520617666171106123226DOI Listing

Publication Analysis

Top Keywords

jak2 ikk
12
stat3 nf-κb
12
nf-κb pathways
8
2-ms-biotin
5
synthesis biotinylated
4
biotinylated 2-methoxystypandrone
4
2-methoxystypandrone identification
4
identification jak2
4
ikk targets
4
targets background
4

Similar Publications

Anthocyanins can prevent and ameliorate type 2 diabetes mellitus (T2DM), but its mechanism of action has not been fully established. IKK/NF-κB and JAK/Stat pathways have multiple effects, triggering T2DM. Liver abnormalities in individuals with T2DM are detrimental to glycemic control.

View Article and Find Full Text PDF

Background/aim: We previously described four different vascular patterns (reticular, diffuse, fasciculate, and trabecular) in renal cell carcinoma (RCC) suggesting an early and heterogeneous acquisition of perivascular cells most probably due to a particular PDGF pathway gene expression profile. The aim of the study was to study PDGF pathway gene expression profiles, separately for each vascular pattern.

Materials And Methods: TaqMan assay for the PDGF pathway was performed on twelve cases of ccRCC previously evaluated by histopathology, immunohistochemistry, and RNAscope.

View Article and Find Full Text PDF
Article Synopsis
  • Empagliflozin (SGLT2 inhibitor) and gemigliptin (DPP-4 inhibitor) have been found to reduce inflammation in macrophages, which could help with conditions like diabetes and obesity, alongside their glucose-lowering effects.
  • The study involved treating macrophages with these drugs after stimulating inflammation with lipopolysaccharide (LPS) and measuring the resulting changes in inflammatory markers.
  • Results showed that both empagliflozin and gemigliptin, alone and in combination, significantly decreased pro-inflammatory cytokines and chemokines, while also inhibiting key inflammatory signaling pathways like NF-κB and MAPK.
View Article and Find Full Text PDF

Ankylosing spondylitis (AS) is a chronic inflammatory disease that mainly affects the spine. AS is highly associated with the expression of HLA-B27. Up to 95% AS patients are HLA-B27-positive.

View Article and Find Full Text PDF

In patients with chronic kidney disease, the abnormal activation of inflammatory pathways is usually an important factor leading to renal fibrosis and further deterioration of renal function. Finding effective intervention targets of the inflammatory signaling pathway is an important way to treat chronic kidney disease. As a newly discovered lysosomal membrane protein, the correlation between SID1 transmembrane family member 2 (Sidt2) and the inflammatory signaling pathway has not been reported.

View Article and Find Full Text PDF